Wenjun completed her master’s training at China Pharmaceutical University. After graduation, she obtained her Ph.D. from Aix-Marseille University in France under the supervision of both Dr. Juan Iovanna’s group at the Cancer Research Center of Marseille and Dr. Ling Peng’s group at the Interdisciplinary Center of Nanoscience of Marseille. There, Wenjun was dedicated to the development of safe and effective targeted therapies and personalized medicine approaches for treating pancreatic cancer. Wenjun joined the Tuveson Laboratory as a Postdoctoral Fellow in 2021 to develop improved pancreatic cancer therapeutics. Wenjun is currently working on investigating the role of an enzyme in the cholesterol metabolism pathway in promoting pancreatic cancer progression and is trying to identify novel strategies to treat patients.